Literature DB >> 16126324

Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.

Alexandre E Pelzer1, Jasmin Bektic, Andreas P Berger, Ethan J Halpern, Florian Koppelstätter, Andrea Klauser, Peter Rehder, Wolfgang Horninger, Georg Bartsch, Ferdinand Frauscher.   

Abstract

OBJECTIVES: The present retrospective study was designed to investigate the value of transition zone (TZ) biopsies for prostate cancer (PC) detection rate in a combined contrast enhanced color Doppler targeted (CECD) and gray-scale systematic biopsy (SB) approach.
METHODS: PSA screening participants totalling 1475 with tPSA of >1.25 ng/ml (fPSA< or =18%) were assessed. Ten SB and additionally 5 or fewer CECD were performed. The impact of TZ biopsies on the PC detection rate and the biological significance of the detected TZ-cancers were analyzed.
RESULTS: Out of 1475 biopsied patients, 395 (26.8%) were identified as PC patients; 5925 biopsy cores from these patients were analyzed. In 86 patients (21.8% of PC), we found 102 PC- positive cores in the TZ, and only in 9 of them solitary TZ-cancers without any other PC-location (2.3% of PC or 0.6% of all investigated patients). Pathologic findings after retropubic prostatectomy (RPE) revealed multifocal adenocarcinoma including involved peripheral zone (PZ) in eight of these nine patients, and solitary TZ-cancer in one patient. There was no positive correlation between prostate volume and TZ-detection rate and no patient with solitary TZ-PC after rebiopsy.
CONCLUSION: Biopsy revealed 9 solitary TZ cancers (1.8%) and RPE revealed only one of them to be truly TZ-confined cancer (0.6%). Furthermore PC-detection did not improve, even in patients with rebiopsy, and there was no correlation between detection of TZ-cancers and prostate volume. A combined use of CECD and SB to investigate participants of a PSA-screening program suggests that TZ-biopsies do not improve PC detection rate and are therefore unnecessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126324     DOI: 10.1016/j.eururo.2005.07.012

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  15 in total

Review 1.  [Prostate biopsy: Procedure in the clinical routine].

Authors:  T Enzmann; T Tokas; K Korte; M Ritter; P Hammerer; L Franzaring; H Heynemann; H-W Gottfried; H Bertermann; M Meyer-Schwickerath; B Wirth; A Pelzer; T Loch
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

2.  Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Authors:  D M Somford; W Vreuls; T S Jansen; J P van Basten; H Vergunst
Journal:  World J Urol       Date:  2013-07-20       Impact factor: 4.226

3.  A new 5-grading score in the diagnosis of prostate cancer with real-time elastography.

Authors:  Guang Xu; Lijing Feng; Minghua Yao; Jian Wu; Lehang Guo; Xudong Yao; Lixia Zhao; Huixiong Xu; Rong Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Is sampling transitional zone in patients who had prior negative prostate biopsy necessary?

Authors:  Bayram Dogan; Ege Can Serefoglu; Ali Fuat Atmaca; Abdullah Erdem Canda; Ziya Akbulut; M Derya Balbay
Journal:  Int Urol Nephrol       Date:  2012-03-15       Impact factor: 2.370

5.  [Optimized standards for prostate biopsy].

Authors:  B Wullich; S Füssel; R Grobholz
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

6.  [Histopathology reports of findings of prostate needle biopsies. Individual treatment].

Authors:  I Damjanoski; J Müller; T J Schnöller; R Küfer; L Rinnab
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

7.  Do prostatic transition zone tumors have a distinct morphology?

Authors:  Joaquin J Garcia; Hikmat A Al-Ahmadie; Anuradha Gopalan; Satish K Tickoo; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

Review 8.  Value of magnetic resonance imaging in prostate cancer diagnosis.

Authors:  Friedrich Aigner; Leo Pallwein; Alexandre Pelzer; Georg Schaefer; Georg Bartsch; Dieter zur Nedden; Ferdinand Frauscher
Journal:  World J Urol       Date:  2007-06-14       Impact factor: 4.226

9.  Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection.

Authors:  Leo Pallwein; Michael Mitterberger; Peter Struve; Wolfgang Horninger; Friedrich Aigner; Georg Bartsch; Johann Gradl; Matthias Schurich; Florian Pedross; Ferdinand Frauscher
Journal:  Eur Radiol       Date:  2007-03-07       Impact factor: 5.315

10.  Potentials and limitations of real-time elastography for prostate cancer detection: a whole-mount step section analysis.

Authors:  Daniel Junker; Georg Schäfer; Friedrich Aigner; Peter Schullian; Leo Pallwein-Prettner; Jasmin Bektic; Wolfgang Horninger; Ethan J Halpern; Ferdinand Frauscher
Journal:  ScientificWorldJournal       Date:  2012-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.